Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-107,879
Closed -$4.68M 1108
2023
Q1
$4.68M Buy
107,879
+101,468
+1,583% +$6.5M 0.18% 99
2022
Q4
$429K Sell
6,411
-22,311
-78% -$1.55M 0.02% 765
2022
Q3
$2.04M Buy
28,722
+21,358
+290% +$1.68M 0.07% 267
2022
Q2
$540K Sell
7,364
-78,731
-91% -$6.36M 0.02% 805
2022
Q1
$7.79M Buy
86,095
+47,371
+122% +$4.47M 0.29% 80
2021
Q4
$3.37M Buy
38,724
+21,851
+130% +$1.88M 0.13% 165
2021
Q3
$1.36M Buy
+16,873
New +$1.21M 0.05% 321
2021
Q2
Sell
-12,387
Closed -$889K 1515
2021
Q1
$889K Sell
12,387
-125,308
-91% -$8.21M 0.03% 395
2020
Q4
$7.69M Buy
+137,695
New +$6.71M 0.25% 97

Other funds holding CMA

Ergoteles's CMA Position: Q2 2023 in Review

Ergoteles sold out of Comerica (CMA) in Q2 2023, closing a stake of 107,879 shares — an estimated $4.68M sold.

Ergoteles first reported a position in CMA in Q4 2020 and held it in 9 quarters. The position peaked at $7.79M in Q1 2022. 490 funds tracked by Wall St. Rank hold CMA as of Q2 2023.

  • Ergoteles reported no remaining Comerica position as of Q2 2023 after selling out during the quarter.
  • Ergoteles sold 107,879 Comerica shares in Q2 2023, an estimated $4.68M.
  • Ergoteles first reported a position in Comerica in Q4 2020 and held it in 9 quarters.
  • Ergoteles's Comerica position peaked at $7.79M in Q1 2022.
  • 490 funds tracked by Wall St. Rank held Comerica as of Q2 2023.

Based on Ergoteles's 13F filing for Q2 2023, filed 14 Aug 2023.